See the latest news and media coverage for Coloplast. We track all announcements, press releases, and industry mentions in real time, all in one place.
Intimate healthcare products and services provider
coloplast.comLast updated
In short: Coloplast named Gavin Wood CEO, posted 6% organic growth, and created a new ownership foundation.
The interim financial report highlights strong performance in Chronic Care ex-China and Interventional Urology, alongside unchanged full-year revenue guidance despite currency headwinds. The company also addresses reimbursement challenges in Biologics and outlines strategic priorities under its new CEO.
The company achieved 6% organic growth across most business areas, maintained a 26% EBIT margin, and provided FY guidance expecting 5-6% organic revenue growth despite macroeconomic headwinds.
He introduced himself and outlined his focus for the first 100 days to listen and learn.
The company also reported 6% EBIT growth in constant currencies, reflecting increased product usage
Niels Peter Louis-Hansen becomes chairman of the new billion-dollar fund, which will be the controlling shareholder in Coloplast.
Coloplast stock stood at DKK 420.60 on Nasdaq Copenhagen on September 24, 2026, after a 0.24 percent daily gain. The latest operating update showed 6...
The Coloplast Foundation has now been established, and with this, the medical company Coloplast has acquired a new major shareholder...
Niels Peter Louis-Hansen will no longer have personal control over Coloplast from around October 1.
Track Coloplast and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Coloplast and other trending companies.
